HomeExpertisePostersACoP 2026, Oxon Hill, MD, USSimplified tau pathology model for preclinical efficacy of PROTAC to investigate translation from in vitro protein degradation to in vivo efficacy
We use cookies (and other similar technologies) to collect data to improve your experience on our site.
By using our website, you agree to data collection as described in our website’s data collection policy.